Capricor Therapeutics, Inc.
CAPR· Nasdaq
Capricor Therapeutics, Inc.
- Last sale
- Oct 2, 2026 · +0.28%
- Market cap
- $520.93M
- 58.14M shares
- Filings
- 962
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of record
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $0 | reported | |
| FY 2024 | 2024-12-31 | $22,270,465 | reported | |
| FY 2023 | 2023-12-31 | $25,178,066 | reported | |
| FY 2022 | 2022-12-31 | $2,600,000 | reported | |
| FY 2021 | 2021-12-31 | $244,898 | reported | |
| FY 2020 | 2020-12-31 | $310,250 | reported | |
| FY 2019 | 2019-12-31 | $1,005,028 | reported | |
| FY 2018 | 2018-12-31 | $1,671,356 | reported | |
| FY 2017 | 2017-12-31 | $2,666,340 | reported | |
| FY 2016 | 2016-12-31 | $3,998,618 | reported | |
| FY 2015 | 2015-12-31 | $5,517,648 | reported | |
| FY 2014 | 2014-12-31 | $4,786,700 | reported |
Capricor Therapeutics, Inc. · CIK 1133869 · Engraved from SEC EDGAR
